The Effectiveness of Steroid Nasal Drops in the Olfactory Cleft Combined With Olfactory Training for Patients With PIOD
NCT07386860 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100
Last updated 2026-02-04
Summary
This study aims to evaluate the effectiveness of hormone nasal drops in the olfactory cleft combined with olfactory training for treating postinfectious olfactory dysfunction (PIOD). The main questions this clinical trial seeks to answer are:
Can the combination of hormone nasal drops and olfactory training improve smell function better than olfactory training alone in PIOD patients? How does this combined treatment work?
Conditions
- Smell Dysfunction
Interventions
- COMBINATION_PRODUCT
-
Steroid nasal drops combined with olfactory training
The intervention consists of two components: steroid nasal drops and modified olfactory training.
- COMBINATION_PRODUCT
-
Placebo nasal drops combined with olfactory training
The intervention consists of two components: normal saline nasal drops and modified olfactory training.
Sponsors & Collaborators
-
Peking University Third Hospital
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- TRIPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-03-01
- Primary Completion
- 2028-12-31
- Completion
- 2028-12-31
Countries
- China
Study Locations
More Related Trials
-
Trial Evaluating the Efficacy of Local Budesonide Therapy in the Management of Hyposmia in COVID-19 Patients Without Signs of Severity
NCT04361474 ·Status: COMPLETED ·Phase: PHASE3
-
Trial of Directed High-dose Nasal Steroids on Residual Smell Loss in Sinus Patients After Sinus Surgery
NCT01814618 ·Status: WITHDRAWN ·Phase: PHASE2
-
Study of Chemosensory Enhancement Through Neuromodulation Training (SCENT for Long COVID)
NCT05855369 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
The Effectiveness of Nasal Corticosteroids Versus Placebo in Nasal Obstruction in Patients With Nasal Septal Deviation
NCT02877485 ·Status: COMPLETED ·Phase: PHASE4
-
Treatment of Pediatric Patients That Lost Sense of Smell Due to COVID-19
NCT04964414 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Factors Influencing the Prognosis of Olfactory Dysfunction After Upper Sensation
NCT04918953 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Effect of Nasal Steroid in the Treatment of Anosmia Due to COVID-19 Disease
NCT04569825 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Administration of Systemic Corticosteroids and the Recovery of Gustatory Functions in Patients With COVID-19
NCT05148832 ·Status: COMPLETED ·Phase: NA
-
Preparation and Characterization Intranasal Film Loaded With Steroid as a Local Treatment of Anosmia in Compare to Insulin Intranasal Film
NCT05328414 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Steroid Nasal Irrigation for Flavor Evaluation and Detection Study
NCT02985515 ·Status: COMPLETED ·Phase: NA
-
Study of the Pathogenesis of Olfactory Disorders in COVID-19
NCT04366934 ·Status: COMPLETED
-
COVID-19 Anosmia Study
NCT04495816 ·Status: COMPLETED ·Phase: PHASE2
-
Impact of Structural and Microenvironmental Abnormalities in Olfactory Cleft on Olfaction in CRS
NCT06834477 ·Status: NOT_YET_RECRUITING
-
Study of the Evolution of Olfactory Disorders in Patients With Persistent Loss of Smell Following COVID-19
NCT05133596 ·Status: COMPLETED ·Phase: NA
-
Sodium Citrate in Smell Retraining for People With Post-COVID-19 Olfactory Dysfunction
NCT06204432 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Stellate Ganglion Block with Lidocaine for the Treatment of COVID-19-Induced Parosmia
NCT06055270 ·Status: RECRUITING ·Phase: PHASE3
-
Stellate Ganglion Block for COVID-19-Induced Olfactory Dysfunction
NCT05445921 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Anosmia and Covid-19
NCT05246059 ·Status: COMPLETED ·Phase: NA
-
Coronavirus Smell Therapy for Anosmia Recovery
NCT04422275 ·Status: WITHDRAWN ·Phase: PHASE2
-
Intranasal Injection of PRP Versus Saline for Treatment of Olfactory Dysfunction
NCT04406584 ·Status: COMPLETED ·Phase: NA
-
CST1-Guided Oral Glucocorticoids Management for CRSwNP
NCT05598411 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Upper Airway Inflammation and Olfaction: Mechanisms of Loss and Recovery
NCT06776042 ·Status: RECRUITING ·Phase: NA
-
Stellate Ganglion Block for COVID-induced Parosmia
NCT06253806 ·Status: COMPLETED ·Phase: PHASE2
-
Steroid Treatment for Elimination of Rebound Obstruction From Intranasal Decongestants
NCT07168148 ·Status: TERMINATED ·Phase: PHASE2
-
Effect of Nasal Steroids in Snoring Intensity
NCT01849406 ·Status: COMPLETED ·Phase: PHASE1